Physician profile
William M Dougherty
NPI 1174968440
$8,420.42
in general payments reported to CMS, 2019-2025
11 companies · $3,704 in 2025
The $3,704 reported for 2025 was more than what 93% of Plastic Surgery Within The Head & Neck providers received nationally (typical 2025 total: $238).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,907 · 2020: $183 · 2023: $13.99 · 2024: $2,612 · 2025: $3,704.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $3,000 · Travel and Lodging: $2,284 · Food and Beverage: $1,046.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $3,000.00 |
| Travel and Lodging | $2,284.14 |
| Food and Beverage | $1,045.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Synthes Gmbh | $5,427.07 | 2024-2025 | |
| Allergan, INC. | $1,830.18 | 2019 | |
| Aerin Medical INC. | $334.06 | 2024-2025 | |
| Medtronic, INC. | $321.92 | 2024-2025 | Nim Vital, Nuvent, Propel |
| Integra Lifesciences Corporation | $183.14 | 2020 | |
| Stryker Corporation | $120.80 | 2025 | Medpor Titan, Na |
| Depuy Synthes Sales INC. | $77.19 | 2019 | |
| Karl Storz Endoscopy-America | $54.89 | 2025 | |
| Acera Surgical, INC. | $39.54 | 2025 | Restrata Wound Matrix |
| Revance Therapeutics, INC. | $17.64 | 2024 | Daxxify |
| Abbvie INC. | $13.99 | 2023 | Botox |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Dougherty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.